New COVID-19 Boosters Target Current Coronavirus Variants

Rochelle Walensky restored morale at the health agency and launched the widest-reaching reforms in decades to strengthen CDC operations.

EBV can persist in our bodies for years and cause increased risk for certain cancers, such as lymphoma, leukemia, and head and neck cancer.

For the millions who are more vulnerable to COVID, reliable data remains important for assessing safety.

Study findings suggest people with chronic liver disease should be prioritized for booster shots.

The findings provide a basis for future studies of the immune system’s role in longevity.

The American Cancer Society and ACS CAN applaud the pick. Bertagnolli, an oncologist, has been running the National Cancer Institute.

People 65 and older and immunocompromised people can get a second bivalent booster; most unvaccinated people now need only one initial shot.

Experimental flu vaccine, designed to elicit immunity against a broad range of influenza viruses, performed well in a small trial.

A second meta-analysis found that people with cirrhosis had higher COVID mortality.

Human papillomavirus and hepatitis B vaccines lower the risk of developing cancer.